Dose-finding studies, MCP-Mod, model selection, and model averaging: Two applications in the real world

Clinical Trials

Volumn 11, Issue 4, 2014, Pages 476-484

  Verrier, Dominique ^a   Sivapregassam, Sïndou ^b   Solente, Anne Catherine ^a  

^a SANOFI   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AVERAGING; CONFERENCE PAPER; DOSE RESPONSE; DRUG INDUSTRY; DRUG RESEARCH; HUMAN; PARALLEL DESIGN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAMPLE SIZE; SECONDARY ANALYSIS; WEIGHT;

EID: 84906093194     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774514532723     Document Type: Conference Paper

References (25)

1. ICH-E4. Topic E4: Dose-Response Information to Support Drug Registration (ICH Harmonized Tripartite Guideline), 1994. Available at: http://www.ich.org/ fileadmin/Public-Web-Site/ICH-Products/Guidelines/Efficacy/E4/Step4/ E4-Guideline.pdf
2. Bornkamp B, Bretz F, Dmitrienko A, et al. Innovative approaches for designing and analyzing adaptive dose-ranging trials. J Biopharm Stat. 2007 ; 17: 965-95
3. Bretz F, Pinheiro JC, Branson M. Combining multiple comparisons and modeling techniques in dose-response studies. Biometrics. 2005 ; 61: 738-48
4. Pinheiro JC, Bornkamp B, Bretz F. Design and analysis of dose-finding studies combining multiple comparisons and modeling procedures. J Biopharm Stat. 2006 ; 16: 639-56
5. Bretz F, Dette H, Pinheiro JC. Practical considerations for optimal designs in clinical dose finding studies. Stat Med. 2010 ; 29: 731-42
6. Bretz F, Hsu J, Pinheiro JC, Liu Y. Dose finding - A challenge in statistics. Biom J. 2008 ; 50: 480-504
7. Dette H, Bretz F, Pepelyshev A, Pinheiro JC. Optimal designs for dose finding studies. J Am Stat Assoc. 2008 ; 103: 1225-37
8. Hu C, Dong Y. Estimating the predictive quality of dose-response after model selection. Stat Med. 2007 ; 26: 3114-39
9. Klingenberg B. Proof of concept and dose estimation with binary responses under model uncertainty. Stat Med. 2009 ; 28: 274-92
10. PinheiroJCBornkampBGlimmEBretzF. Model-based dose finding under model uncertainty using general parametric models. Stat Med2013. Available at: http://arxiv.org/abs/1305.0889v2
11. Selmaj K, Li DK, Hartung HP, et al. Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): An adaptive, dose-ranging, randomised, phase 2 study. Lancet Neurol. 2013 ; 12: 756-67
12. Villa G, Le Breton S, Ibram G, Keefe DL. Efficacy, safety, and tolerability of aliskiren monotherapy administered with a light meal in elderly hypertensive patients: A randomized, double-blind, placebo-controlled, dose-response evaluation study. J Clin Pharmacol. 2012 ; 52: 1901-11
13. Calhoun DA, White WB, Krum H, et al. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: Results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation. 2011 ; 124: 1945-55
14. So A, De Meulemeester M, Pikhlak A, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study. Arthritis Rheum. 2010 ; 62: 3064-76
15. Ruilope LM, Dukat A, Böhm M, et al. Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: A randomised, double-blind, placebo-controlled, active comparator study. Lancet. 2010 ; 375: 1255-66
16. Buckland ST, Burnham KP, Augustin NH. Model selection: An integral part of inference. Biometrics. 1997 ; 53: 603-18
17. Claeskens G, Hjort NL. The focused information criterion. J Am Stat Assoc. 2003 ; 98: 900-16
18. Shen X, Huang H-C, Ye J. Inference after model selection. J Am Stat Assoc. 2004 ; 99: 751-62
19. Hjort NL, Claeskens G. Frequentist model average estimators. J Am Stat Assoc. 2003 ; 98: 879-99
20. Hoeting JA, Madigan D, Raftery AE, Volinsky CT. Bayesian model averaging: A tutorial. Stat Sci. 1999 ; 14: 382-417
21. Raftery AE. Bayesian model selection in social research. Sociol Methodol. 1995 ; 25: 111-63
22. Burnham KP, Anderson DR. Multimodel inference understanding AIC and BIC in model selection. Sociol Methods Res. 2004 ; 33: 261-304
23. Bornkamp B Comparison of model-based and model-free approaches for the analysis of dose-response studies. Dortmund: Diplomarbeit, Dortmund University ; 2006 :
24. Faes C, Aerts M, Geys H, Molenberghs G. Model averaging using fractional polynomials to estimate a safe level of exposure. Risk Anal. 2007 ; 27: 111-23
25. Dette H, Bornkamp B, Bretz F. On the efficiency of two-stage response-adaptive designs. Stat Med. 2013 ; 32: 1646-60